Zai Lab (ZLAB) Cash from Operations (2018 - 2026)
Zai Lab (ZLAB) posted quarterly Cash from Operations of 11912000.0 for Q1 2026, up 80.69% year-on-year from 6592383.69 in Q1 2025, and up 54.22% on a QoQ basis from 26022000.0 in Q4 2025.
Zai Lab (ZLAB) Cash from Operations (2018 - 2026) Analysis & Trends
Zai Lab (ZLAB) has reported Cash from Operations for 9 consecutive years, with 11912000.0 the latest figure, recorded in Q1 2026.
- Quarterly Cash from Operations rose 80.69% year-over-year to 11912000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 101002000.0 (up 45.83% YoY) and the FY2025 annual result came in at 150789000.0, up 29.82% from the prior year.
- Cash from Operations advanced to 11912000.0 in Q1 2026 per ZLAB's latest filing, from 26022000.0 in the prior quarter.
- Over the last five years, Cash from Operations for ZLAB reached as high as 11912000.0 in Q1 2026 and fell as low as 126323000.0 in Q3 2022.
- A 5-year average of 55493529.41 and a median of 55272000.0 in 2023 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2023 — Cash from Operations soared 86.35% — and 2024, when it tumbled 273.86%.
- Year by year, Cash from Operations stood at 109292000.0 in 2022, then surged by 86.35% to 14917000.0 in 2023, then slumped by 273.86% to 55769000.0 in 2024, then jumped by 53.34% to 26022000.0 in 2025, then jumped by 54.22% to 11912000.0 in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered 11912000.0, 26022000.0, and 32044000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Zai Lab | 22.02 Bn | 22.02 Bn | 61.30 Mn | -11.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.91 Mn |
| Mar 31, 2026 | -11.91 Mn |
| Dec 31, 2025 | -26.02 Mn |
| Dec 31, 2025 | -26.02 Mn |
| Sep 30, 2025 | -32.04 Mn |
| Sep 30, 2025 | -32.04 Mn |
| Jun 30, 2025 | -31.02 Mn |
| Jun 30, 2025 | -31.02 Mn |
| Mar 31, 2025 | -61.70 Mn |
| Mar 31, 2025 | -61.70 Mn |
| Dec 31, 2024 | -55.77 Mn |
| Dec 31, 2024 | -55.77 Mn |
| Sep 30, 2024 | -26.82 Mn |
| Sep 30, 2024 | -26.82 Mn |
| Jun 30, 2024 | -42.17 Mn |
| Jun 30, 2024 | -42.17 Mn |
| Mar 31, 2024 | -90.11 Mn |
| Mar 31, 2024 | -90.11 Mn |
| Dec 31, 2023 | -14.92 Mn |
| Dec 31, 2023 | -14.92 Mn |